Literature DB >> 11709621

Etanercept-induced subacute cutaneous lupus erythematosus.

G S Bleumink, E J ter Borg, C G Ramselaar, B H Stricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11709621     DOI： 10.1093/rheumatology/40.11.1317

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  12 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

Review 2.  Safety of etanercept in psoriasis: a critical review.

Authors:  Jose L Sánchez Carazo; Laura Mahiques Santos; Vicente Oliver Martinez
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.

Authors:  Paola Caramaschi; Domenico Biasi; Elisabetta Tonolli; Sara Pieropan; Nicola Martinelli; Antonio Carletto; Alessandro Volpe; Lisa Maria Bambara
Journal:  Rheumatol Int       Date:  2005-02-23       Impact factor: 2.631

4.  Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus.

Authors:  S Zampieri; M Alaibac; L Iaccarino; R Rondinone; A Ghirardello; P Sarzi-Puttini; A Peserico; A Doria
Journal:  Ann Rheum Dis       Date:  2005-08-11       Impact factor: 19.103

5.  A case of cellulitis causing tissue defect during etanercept therapy.

Authors:  Dulgeroglu Deniz; Umay Ebru; Bal Ajda; Tetik Menevse Gulsum; Tatlican Semih; Cakci Aytul
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

Review 6.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity.

Authors:  Paola Caramaschi; Domenico Biasi; Marco Colombatti; Sara Pieropan; Nicola Martinelli; Antonio Carletto; Alessandro Volpe; Luisa Maria Pacor; Lisa Maria Bambara
Journal:  Rheumatol Int       Date:  2004-12-31       Impact factor: 2.631

8.  [Cutaneous lupus erythematosus. Part 2: diagnostics and therapy].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

9.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

Review 10.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.